Abstract
THE administration to a patient of substances containing iodine may result in spurious alterations of the thyroidal uptake of iodine and the level of serum protein-bound iodine. If the physician is unaware of the prior administration of such a drug, or is not familiar with its potentialities in this regard, he may be confused by the results of such tests. With the constant production of new therapeutic agents, additional drugs are likely to be introduced that will interfere with these parameters of thyroid function. When it was noted that a preparation of meprobamate with an anticholinergic drug contained iodine, it . . .
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
